Boston Childrens Hospital

Running trials

• Recruiting

  ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)

  NCT07448610· Phase 4· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

  NCT07227454· Phase 3· Source

• Not yet recruiting

  CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome

  NCT06738732· Phase 1/2· Source

• Recruiting

  Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)

  NCT06593951· Source

• Recruiting

  A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  NCT06546670· Phase 1/2· Source

• Recruiting

  A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  NCT05923073· Phase 3· Source

• Enrolling by invitation

  Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

  NCT06262282· Source

• Active, not recruiting

  A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

  NCT04075266· Phase 2· Source

• Recruiting

  Effects of Ketosis on Brain Function in Patients With T1DM

  NCT04219709· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy2 recruiting
• Crohn's disease1 recruiting
• Cystic fibrosis1 recruiting
• Depression1 recruiting
• Sickle cell disease1 recruiting
• Spinal muscular atrophy1 recruiting
• Tuberculosis1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

  NCT06506773· Source

• Completed

  Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam

  NCT05386680· Phase 3· Source

• Completed

  A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy

  NCT05115110· Phase 2/3· Source

• Completed

  A Study of Risdiplam (RO7034067) in Adult and Pediatric Participants With Spinal Muscular Atrophy

  NCT03032172· Phase 2· Source

• Completed

  Investigate Safety, Tolerability, PK, PD and Efficacy of Risdiplam (RO7034067) in Infants With Type1 Spinal Muscular Atrophy

  NCT02913482· Phase 2· Source